ADDEX N/ CH0029850754 /
2024-03-28 5:30:28 PM | Chg. -0.0016 | Volume | Bid5:40:00 PM | Ask5:40:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
0.0956CHF | -1.65% | 349,888 Turnover: 33,055.6222 |
0.0852Bid Size: 10,000 | 0.0960Ask Size: 420,000 | 5.71 mill.CHF | - | - |
GlobeNewswire
01-31
Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.
GlobeNewswire
2023-11-23
Addex Therapeutics to Release Third Quarter 2023 Financial Results and Host Conference Call on Novem...
GlobeNewswire
2023-11-07
US Neurologists Emphasize Tremendous Unmet Treatment Need in Parkinson's Disease, According to Spher...
GlobeNewswire
2023-09-06
Addex Announces Participation in the H.C. Wainwright 25th Annual Global Investment Conference
GlobeNewswire
2023-09-04
Addex’s Dipraglurant Development in Post-Stroke Recovery Supported by Data Published in Brain
GlobeNewswire
2022-03-24
Addex to Present at the Bio-Europe Spring 2022 and Maxim Group – 2022 Virtual Growth Conferences
GlobeNewswire
2022-03-10
Addex Reports Full Year 2021 Financial Results and Provides Corporate Update
GlobeNewswire
2022-03-07
Addex Therapeutics to Release Full-Year 2021 Financial Results and Host Conference Call on March 10,...